Quick Answer
Fortress Biotech, Inc. reported Earnings Per Share Diluted of $0.07 (loss) per share for the year ending 2025.
- Fortress Biotech, Inc. showed an increase of +97.4% in Earnings Per Share Diluted from 2024 to 2025.
- This data is from Fortress Biotech, Inc.'s annual report (Form 10-K), filed with the SEC on March 31, 2026.
- XBRL data for this metric is available from 2021 to 2025 (5 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2018: $0.49 (loss) per share | Q1 2019: $0.02 per share | Q1 2020: $0.19 (loss) per share | Q1 2021: $0.11 (loss) per share | Q2 2021: $0.04 (loss) per share | Q3 2021: $0.26 (loss) per share | Q1 2022: $0.18 (loss) per share | Q2 2022: $0.26 (loss) per share | Q3 2022: $4.11 (loss) per share | Q1 2023: $0.21 (loss) per share | Q2 2023: $3.65 (loss) per share | Q3 2023: $0.94 (loss) per share | Q1 2024: $1.04 (loss) per share | Q2 2024: $0.73 (loss) per share | Q3 2024: $0.76 (loss) per share | Q1 2025: $0.48 (loss) per share | Q2 2025: $0.45 per share | Q3 2025: $0.11 per share.
- Over the full 5 years of available data (2021 to 2025), Fortress Biotech, Inc.'s Earnings Per Share Diluted has grown by 91.1%.
- Historical annual values: Fiscal year 2025: $0.07 (loss) per share | Fiscal year 2024: $2.69 (loss) per share | Fiscal year 2023: $8.47 (loss) per share | Fiscal year 2022: $15.97 (loss) per share | Fiscal year 2021: $0.79 (loss) per share.
- Data sourced from SEC EDGAR public filings as of August 9, 2026.
Last verified: